Innovative Pain Treatments Zalicus specializes in discovering and developing novel therapeutics for pain management, particularly targeting chronic neuropathic and inflammatory pain. This positions the company as a potential partner or supplier for pharmaceutical firms seeking advanced pain treatment solutions.

Collaborative Revenue Streams The company has established multiple revenue-generating collaborations with large pharmaceutical organizations, highlighting opportunities for strategic partnerships, licensing agreements, or joint ventures to expand market reach and accelerate product development.

Technology-Driven Discovery Utilizing proprietary high-throughput screening and expertise in ion channel modulation, Zalicus offers cutting-edge drug discovery services, making it a suitable collaborator for pharma companies seeking innovative research technologies and clinical-stage candidates.

Market Expansion Potential With a focus on pain, inflammation, oncology, and infectious disease, Zalicus presents opportunities to expand into diverse therapeutic areas, appealing to larger firms aiming to diversify their pipeline through licensing or acquisition of advanced candidates.

Growing Biotech Profile Although a small company with a limited income stream, Zalicus's merger with Epirus and ongoing research activities position it as a potential partner for biotech firms or investors interested in emerging pain therapeutics and ion channel research innovations.